|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.325 SEK | -1.85% |
|
+16.23% | -27.20% |
| Jul. 16 | Flerie Concludes Mandatory Cash Offer for Nanologica | MT |
| Jul. 16 | Minimal Acceptance for Flerie's Mandatory Offer on Nanologica | FW |
Company Valuation: Nanologica AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 372.2 | 385.9 | 281.7 | 375.9 | 160.8 | 117.1 | - | - |
| Change | - | 3.67% | -27.01% | 33.47% | -57.22% | -27.19% | - | - |
| Enterprise Value (EV) | 372.2 | 385.9 | 279.3 | 375.9 | 163.3 | 117.1 | 117.1 | 117.1 |
| Change | - | 3.67% | -27.63% | 34.61% | -56.55% | -28.32% | 0% | 0% |
| P/E ratio | -14.4x | -8.56x | -5.43x | - | - | - | - | - |
| PBR | - | 7.49x | 4.94x | - | - | - | - | - |
| PEG | - | -0.1x | -0.4x | - | - | - | - | - |
| Capitalization / Revenue | 23.1x | 29.9x | 181x | 261x | 11.1x | 2.7x | 1.17x | 0.79x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.7x | 1.17x | 0.79x |
| EV / EBITDA | - | -0x | -0x | -0x | -0x | -4.92x | 8.67x | 4.5x |
| EV / EBIT | - | -0x | -0x | -0x | -0x | -2.94x | -39x | 13x |
| EV / FCF | - | -7.18x | -5.33x | -6.62x | - | - | - | - |
| FCF Yield | - | -0% | -0% | -0% | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.93 | -1.6 | -1.84 | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 16.14 | 12.91 | 1.555 | 1.443 | 14.54 | 43.3 | 100.2 | 148.8 |
| EBITDA 1 | - | -30.23 | -38.99 | -50.6 | -32.03 | -23.8 | 13.5 | 26 |
| EBIT 1 | - | -40.69 | -50.85 | -69.96 | -59.26 | -39.8 | -3 | 9 |
| Net income | - | -44.83 | -55.23 | - | - | - | - | - |
| Net Debt | - | - | -2.388 | - | 2.536 | - | - | - |
| Reference price 2 | 13.400 | 13.700 | 10.000 | 10.400 | 1.820 | 1.325 | 1.325 | 1.325 |
| Nbr of stocks (in thousands) | 27,777 | 28,166 | 28,166 | 36,146 | 88,357 | 88,370 | - | - |
| Announcement Date | 2/26/21 | 2/8/22 | 2/10/23 | 2/2/24 | 2/14/25 | - | - | - |
1SEK in Million2SEK
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 12.12M | ||
| 19.5x | 4.21x | 10.71x | 5.9% | 21.35B | ||
| -74.72x | 0.78x | 8.88x | 9.86% | 20.03B | ||
| 32.44x | 0.88x | 5.65x | 0.48% | 14.63B | ||
| -77.43x | 1x | 14.53x | -.--% | 13.29B | ||
| 59.95x | 1.68x | 41.32x | 1.14% | 8.4B | ||
| 45.9x | 4.48x | 30.49x | 0.82% | 6.22B | ||
| 212.98x | 0.67x | 13.14x | 2.08% | 5.05B | ||
| 19.9x | 1.58x | 13.66x | 1.75% | 4.86B | ||
| 20.9x | - | - | 2.29% | 3.93B | ||
| Average | 28.82x | 1.91x | 17.30x | 2.7% | 9.78B | |
| Weighted average by Cap. | 4.19x | 1.97x | 14.41x | 3.82% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- NICA Stock
- Valuation Nanologica AB
Select your edition
All financial news and data tailored to specific country editions
